Fig4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about FIG4 Protein, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
| FIG4 Protein | |
|---|---|
| Protein Name | FIG4 Phosphoinositide 5-Phosphatase |
| Gene | FIG4 |
| UniProt ID | Q8IZ73 |
| PDB ID | 5W5V |
| Molecular Weight | 103 kDa |
| Subcellular Localization | Cytoplasmic vesicles, endosomes, lysosomes |
| Protein Family | FIG4 family, SAC1-like phosphatases |
FIG4 is a member of the SAC1-like phosphoinositide phosphatase family. The protein contains a conserved catalytic core with the Cx5R motif essential for phosphatase activity. FIG4 localizes to cytoplasmic vesicles, particularly late endosomes and lysosomes, where it regulates phosphoinositide signaling.
FIG4 functions as a phosphoinositide 5-phosphatase that specifically dephosphorylates PI(3,5)P2 to PI3P:
FIG4 mutations cause autosomal dominant ALS with variable phenotypes:
FIG4 variants are risk factors for PD:
Recessive FIG4 mutations cause severe peripheral neuropathy:
| Variant | Disease | Mechanism |
|---|---|---|
| I41T | ALS | Partial loss of function |
| R389Q | ALS | Dominant negative |
| L17P | CMT4J | Complete loss of function |
FIG4 mutations cause CMT type 4J, characterized by demyelination, sensory loss, and progressive distal muscle weakness. The disease typically presents in adolescence or early adulthood[^1].
FIG4 deficiency contributes to ALS pathogenesis through impaired endolysosomal trafficking and autophagy. Reduced FIG4 levels have been observed in sporadic ALS patients[^2].
FIG4 variants may increase PD risk through effects on lysosomal function and alpha-synuclein clearance.
Current therapeutic approaches include:
The study of Fig4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.